BRIEF-Rogers Enters Into Definitive Agreement To Sell Portfolio Of Data Centres-February 2024-www.financetom.com

BRIEF-Rogers Enters Into Definitive Agreement To Sell Portfolio Of Data Centres

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Rogers Enters Into Definitive Agreement To Sell Portfolio Of Data Centres

Aug 14, 2025 6:39 AM

Aug 14 (Reuters) - Rogers Communications Inc ( RCIAF ):

* ROGERS ENTERS INTO DEFINITIVE AGREEMENT TO SELL PORTFOLIO

DATA CENTRES

* ROGERS ENTERS INTO DEFINITIVE AGREEMENT TO SELL PORTFOLIO

DATA CENTRES

* ROGERS COMMUNICATIONS INC ( RCIAF ) - TO SELL PORTFOLIO OF NINE

ROGERS

BUSINESS DATA CENTRES TO BROOKFIELD INFRARED

Source text:

Further company coverage:

Previous page： Neo Performance Materials to Sell China Rare Earth Separation Assets for US$30 Million Next page： Eli Lilly says weight-loss drug cut diabetes risk by 94% in trial

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Neo Performance Materials to Sell China Rare Earth Separation Assets for US$30 Million

Aug 20, 2024

06:53 AM EDT, 08/20/2024 (MT Newswires) -- Neo Performance Materials ( NOPMF ) , which makes advanced industrial materials, on Tuesday said it will sell its stakes in China rare earth separation assets for a total of US$30 million. The transactions, which are expected to close in the fourth quarter, are subject to approval by regulatory authorities in China. Neo...

Eli Lilly says weight-loss drug cut diabetes risk by 94% in trial

Aug 20, 2024

Aug 20 (Reuters) - Eli Lilly ( LLY ) said on Tuesday its weight loss drug cut the risk of developing diabetes by 94% in patients with pre-diabetes or those who were obese or overweight in a long-term study. Treatment with tirzepatide, which is the active ingredient in Lilly's Zepbound and Mounjaro treatments, also resulted in 22.9% average decrease in...

Medtronic raises annual profit forecast on medical devices strength

Aug 20, 2024

Aug 20 (Reuters) - Medtronic ( MDT ) lifted its annual profit forecast on Tuesday, banking on sustained demand for its medical devices following a rise in surgeries and procedures. The company expects profit of between $5.42 and $5.50 per share for the fiscal year 2025, compared with its earlier forecast of $5.40 to $5.50. (Reporting by Sriparna Roy and...

H World Group's Q2 Adjusted Earnings, Revenue Rise; Q3 Revenue Guidance Issued

Aug 20, 2024

06:53 AM EDT, 08/20/2024 (MT Newswires) -- H World Group ( HTHT ) reported Q2 adjusted earnings Tuesday of 3.88 Chinese renminbi ($0.54) per diluted American depositary share, up from 3.29 renminbi a year earlier. Two analysts polled by Capital IQ expected 3.03 renminbi. Revenue for the quarter ended June 30 was 6.15 billion renminbi, up from 5.53 billion renminbi...